Doctor Theiss Salvia extract with vitamine C (Tablets) Instructions for Use
Marketing Authorization Holder
Dr. Theiss Naturwaren GmbH (Germany)
ATC Code
R05CA10 (Expectorants in combination)
Active Substances
Ascorbic acid (Rec.INN registered by WHO)
Salvia (BP British Pharmacopoeia)
Dosage Form
| Doctor Theiss Salvia extract with vitamine C | Sublingual tablets: 12 or 24 pcs. |
Dosage Form, Packaging, and Composition
| Sublingual tablets | 1 tab. |
| Ascorbic acid | 20 mg |
| Sage oil | 6 mg |
| Salvia officinalis extract | 50 mg |
12 pcs. – contour cell packs (1) – cardboard packs.
12 pcs. – contour cell packs (2) – cardboard packs.
Clinical-Pharmacological Group
Herbal preparation with antimicrobial and anti-inflammatory action for local use in ENT practice and dentistry
Pharmacotherapeutic Group
Antiseptic of plant origin
Pharmacological Action
A combined preparation that has antiseptic, astringent, antispasmodic, anti-inflammatory, expectorant, and hemostatic effects.
It normalizes the permeability of vascular and capillary walls, activates the synthesis of collagen and procollagen, and is active against gram-positive microorganisms (to a lesser extent – gram-negative).
Indications
- Inflammatory conditions of the upper and lower respiratory tract including acute and chronic tonsillitis, pharyngitis, laryngitis, tracheitis, and bronchitis.
- Symptomatic relief of acute upper respiratory viral infections (ARVI) to address associated discomfort and inflammation in the oral cavity and throat.
- Oral cavity disorders specifically for the management of gum bleeding, including cases associated with periodontal disease.
ICD codes
| ICD-10 code | Indication |
| J02 | Acute pharyngitis |
| J03 | Acute tonsillitis |
| J04 | Acute laryngitis and tracheitis |
| J06.9 | Acute upper respiratory infection, unspecified |
| J20 | Acute bronchitis |
| J31.2 | Chronic pharyngitis |
| J35.0 | Chronic tonsillitis |
| J37 | Chronic laryngitis and laryngotracheitis |
| J42 | Unspecified chronic bronchitis |
| K05 | Gingivitis and periodontal diseases |
| ICD-11 code | Indication |
| CA02.Z | Acute pharyngitis, unspecified |
| CA03.Z | Acute tonsillitis, unspecified |
| CA05 | Acute laryngitis or tracheitis |
| CA07.0 | Acute upper respiratory tract infection of unspecified site |
| CA09.2 | Chronic pharyngitis |
| CA0F.Y | Other specified chronic diseases of the palatine tonsils and adenoids |
| CA0G | Chronic laryngitis or laryngotracheitis |
| CA20.1Z | Chronic bronchitis, unspecified |
| CA42.Z | Acute bronchitis, unspecified |
| DA0B.Z | Gingival diseases, unspecified |
| DA0C.Z | Periodontal diseases, unspecified |
| DA0Z | Diseases or disorders of the orofacial complex, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer orally, allowing one sublingual tablet to dissolve slowly in the mouth. Do not chew or swallow the tablet whole.
Adhere to a dosing schedule of one lozenge every two to three hours as required for symptomatic relief. The maximum daily intake should not exceed the number of tablets specified in the package instructions.
Adverse Reactions
Monitor for signs of hypersensitivity reactions, which may present as skin rash, pruritus, urticaria, or angioedema.
Discontinue use immediately upon the appearance of any allergic symptoms and seek medical advice. Local irritation in the oral mucosa is also possible but less frequently reported.
Drug Interactions
Exercise caution with concurrent use of anticoagulant or antiplatelet medications, such as warfarin or aspirin, due to potential enhancement of effects from salvia components.
Avoid concomitant administration with other topical oral antiseptics as this may reduce the efficacy of either product. Maintain a minimum interval of 30 minutes between uses of different oral preparations.
Contraindications
- Known hypersensitivity to any of the active substances (ascorbic acid, salvia extract, sage oil) or to any of the excipients listed in the product composition.
- Patients with a history of severe allergic reactions, particularly to plants of the Lamiaceae family, which includes sage, mint, and basil, due to the risk of cross-reactivity.
Overdose
In case of accidental ingestion of a significantly large number of tablets, promptly seek medical attention or contact a poison control center.
Symptoms of overdose may primarily involve gastrointestinal discomfort, such as nausea, abdominal pain, or diarrhea, largely attributable to the high dose of ascorbic acid. Provide symptomatic and supportive care as no specific antidote exists.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer